Welcome

Bridges to Better Medicine brings together world class scientists and business leaders in the life sciences - venture capitalists, biotechnology and pharmaceutical executives, healthcare investors and analysts. The Rockefeller University believes that fostering a robust intellectual exchange between academia and industry is critical to advancing biomedical breakthroughs.

Bridges offers you opportunities to:

  • hear about the latest scientific and medical innovations from inside the lab and from industry;
  • interact with top scientists and industry leaders in a private setting;
  • develop valuable relationships and exchange ideas with peers.

Through this program, The Rockefeller University hopes to develop friendships and inspire philanthropy among individuals in life science-related businesses.

Register to become a member

Upcoming Events

Insight Lecture

Wednesday, January 29, 2014
6:00 - 7:00 p.m.

The Discovery of Insulin: A Life-Saving Achievement, the First Nobel Controversy, and Rockefeller's Underappreciated Role

Featured Speakers:
Arthur Ainsberg
Jeffrey M. Friedman, M.D., Ph.D

Register Now

News

 
Robert Darnell named president of New York Genome Center
Robert B. Darnell, Robert and Harriet Heilbrunn Professor and head of the Laboratory of Molecular Neuro-oncology, will direct all aspects of the NYGC, including its scientific and research activities, and the recruitment and development of a world-class scientific team in genomic research and medicine.
Vitamin D supplements do not improve cholesterol as previous research suggested
Vitamin D has been touted for its beneficial effects on a range of human systems.  But it does not improve cholesterol levels, according to a new study conducted at The Rockefeller University Hospital.
Protein proves vital in immune response to bacteria
Scientists have discovered that a protein once thought to be mainly involved in antiviral immunity is in fact more important in fighting bacterial infections.
Rockefeller creates Cohn-Steinman Professorship to honor discoverers of dendritic cells
The family of the late Ralph Steinman, who died three days before winning the Nobel Prize, will donate much of the proceeds from the award to establish the Cohn-Steinman Professorship at Rockefeller. The professorship will create an enduring memorial to Steinman and his mentor and collaborator, Zanvil Cohn.
Rockefeller creates Cohn-Steinman Professorship to honor discoverers of dendritic cells
The family of the late Ralph Steinman, who died three days before winning the Nobel Prize, will donate much of the proceeds from the award to establish the Cohn-Steinman Professorship at Rockefeller. The professorship will create an enduring memorial to Steinman and his mentor and collaborator, Zanvil Cohn.
Albany Medical Center Prize awarded to James E. Darnell, Jr. and Robert G. Roeder
Darnell and Roeder are being recognized for helping to define how cells grow, replicate, and become specialized, and in turn giving medical professionals and researchers the tools to improve health and combat diseases.
$15 million gift from Helmsley Trust to fund research on digestive diseases
Funds will establish a new center, to be known as the Center for Basic and Translational Research on Disorders of the Digestive System, which will support interdisciplinary basic research and foster collaborations among some 20 Rockefeller labs.
In cancer, molecular signals that recruit blood vessels also trigger metastasis
Cancer cells are most deadly when they’re on the move.  New research has now shown how a miRNA prevents the recruitment and formation of blood vessels near cancer cells destined to become metastases.
Statin-intolerant patients need a different type of clinical trial
Although only 5% of people in clinical trials report side effects from statin drugs, in practice the problem is far greater. Clinical trials need to better address the needs of statin-intolerant patients, Rockefeller researchers say.

Read More

Marc Tessier-Lavigne, Ph.D.
President
The Rockefeller University

Moderator

Barry Coller, M.D.
Vice President for Medical Affairs and Physician-in-Chief
The Rockefeller University

Director
Center for Clinical and Translational Science

Co-Chairs

Anthony B. Evnin, Ph.D.
General Partner
Venrock

Robin Chemers Neustein
Senior Director
Goldman, Sachs & Co.

Steering Committee

Ron Cohen, M.D.
Acorda Therapeutics

Kathleen Denis, Ph.D.
The Rockefeller University

David Elliman
Elmrock Capital

Emilio Emini, Ph.D.
Pfizer

Teena Lerner, Ph.D.
Rx Capital Management

Paul Maddon, M.D., Ph.D.
Progenics Pharmaceuticals

Brad Margus
Envoy Therapeutics

Sharon Mates, Ph.D.
Intra-Cellular Therapies

Robin Chemers Neustein
Goldman, Sachs & Co.

Russell Pennoyer
Benedetto, Gartland & Co.

Geoff Smith
Ascent Biomedical Ventures

George Yancopoulos, M.D., Ph.D.
Regeneron Pharmaceuticals

bridges@rockefeller.edu

RSS Facebook Twitter YouTube

The Rockefeller University | 1230 York Avenue, New York, NY 10065 | 212-327-8000
Copyright © 2004–2013 The Rockefeller University. All rights reserved.
Contact | Comments | Site Map | Copyright Complaints | Mobile Site | Privacy Policy